Safe-T Group (NASDAQ:SFET) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.60) by 88.33 percent. This is a 93.64 percent increase over losses of $(1.10) per share from the same period last year. The company reported quarterly sales of $4.81 million which beat the analyst consensus estimate of $4.75 million by 1.31 percent. This is a 42.49 percent increase over sales of $3.38 million the same period last year.
This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.
